AME

Business profile & competitive position

AMETEK, Inc. (AME) operates in the Industrials sector, specifically the Electrical Equipment & Parts industry. The company manufactures electronic instruments and electromechanical devices through two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG designs and manufactures advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets, while EMG supplies precision motion control solutions, thermal management systems, specialty metals, electrical interconnects and highly engineered medical components to aerospace and defense, medical, automation and other industrial markets. This is not a commodity electrical-component business; it is a portfolio of specification-critical products tied to engineering collaboration and long customer-qualification cycles.

The profitability numbers support the view that AMETEK holds above-average pricing power for a diversified industrial manufacturer. The current snapshot shows a 20.0% net margin and a 14.5% return on equity. A one-in-five net margin is high within the broader industrials peer set, and ROE in the mid-teens exceeds typical cost-of-capital hurdles. Those figures do not prove an unassailable moat, but they do indicate that the company has been able to combine price realization with cost discipline to convert sales into both bottom-line profit and equity returns.

Financial posture

As of the current snapshot, AMETEK has a $53.6 billion market capitalization and trades at a trailing P/E of 34.1. That multiple is clearly at a premium to the average diversified industrial manufacturer and reflects the market’s willingness to pay up for consistent earnings quality. The 20.0% net margin and 14.5% ROE provide fundamental support for that premium: the company is both profitable on a per-sale basis and efficient at generating returns on shareholders’ equity.

The stock’s beta is 0.99, essentially one, which implies AMETEK has historically moved close to line with the broader equity market. At a price of $234.06, it sits below its 50-day exponential moving average of $239.67, and the RSI at 43.1 reads as neutral-to-slightly-weak. Those technical reads line up with the September 3, 2026 Zacks headline noting the stock was down 8.5% since its most recent earnings report. These figures describe valuation and short-term momentum; they do not suggest any action.

Strategic priorities & outlook

AMETEK’s most recent 10-K frames the company as a leading global manufacturer selling worldwide through EIG and EMG. Its official strategy is organized around the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. The operational playbook includes Operational Excellence initiatives spanning lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions are a deliberate centerpiece of the model. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing approximately $1.8 billion in annualized sales. In 2025 alone it spent $933.2 million in cash, net of cash acquired, to purchase Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). The financial results show the strategy working at the top line: 2025 sales reached $7,401.1 million, up 6.6% from 2024, and diluted EPS came in at $6.40, up 7.9%. The filing also highlighted record operating income, net income, orders and backlog.

Global expansion remains a structural priority. In 2025, 52% of EIG’s net sales and 42% of EMG’s net sales went to customers outside the United States. To support international growth and maintain best-cost manufacturing, AMETEK operates facilities in China, Czechia, Malaysia, Mexico and Serbia. As of December 31, 2025, the company employed approximately 22,500 people. The broader strategy is to compound earnings through organic productivity, disciplined bolt-on M&A and geographic penetration.

Macro & geopolitical exposure

AMETEK’s position in Electrical Equipment & Parts places it in the middle of several macroeconomic cycles. Demand is tied to capital spending by manufacturers, utilities and aerospace/defense primes, which is sensitive to interest rates, credit availability and industrial confidence. A sustained pullback in industrial capex would likely pressure order rates and backlog conversion.

Supply-side exposure is also material. Precision instruments and electromechanical devices depend on inputs such as semiconductors, specialty metals, copper, magnets and rare-earth elements. Disruptions, export controls or price increases in those materials can affect margins. Currency risk is direct: with roughly half of each segment’s 2025 sales outside the United States, a stronger dollar would mechanically reduce the translated value of non-dollar revenue.

Regulatory and trade-policy risk is inherent to the industry as well. Aerospace and defense sales can face export controls and contract-timing volatility; medical components are subject to device-regulation standards; and electrical equipment faces safety, environmental and efficiency rules. Tariffs or trade restrictions involving key production locations such as China, Mexico or Southeast Asia could add cost complexity or force sourcing adjustments. AMETEK’s presence in China, Czechia, Malaysia, Mexico and Serbia gives it geographic diversification, yet it also ties the company to local political and trade developments.

Recent developments

The most recent news flow captures both the M&A engine and the recent stock weakness. On August 26, 2026, PR Newswire reported that AMETEK completed its acquisition of Indicor Instrumentation, continuing the strategy of tuck-in deals in measurement and instrumentation. On September 4, 2026, Seeking Alpha noted Baron SMID Cap ETF’s Q2 2026 portfolio activity, a reminder that AMETEK is held and reshuffled by active fund managers. One day earlier, on September 3, 2026, Zacks highlighted that the stock was down 8.5% since its last earnings report, matching the current price’s position below the 50-day EMA. Separately, on September 1, 2026, Seeking Alpha published a longer thesis calling AMETEK “The Quiet Control Layer Behind the Next Industrial Investment Cycle,” an argument that fits the EIG/EMG positioning described above.

Earnings behavior & post-earnings drift

AMETEK’s earnings track record is unusually consistent. Over the last eight reported quarters, the company has beaten EPS estimates every time: an 8/8 beat rate with an average earnings surprise of 4%. The post-earnings price reaction, however, has been much more muted.

In the last four reported quarters, AMETEK beat estimates each time but recorded mixed near-term price responses. On August 4, 2026, the company reported actual EPS of $2.09 versus an estimate of $1.99, a 5% surprise; the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, actual EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and drifted down 0.33% over the next five sessions. On February 3, 2026, actual EPS of $2.01 beat the $1.94 estimate by 3.6%, with a 0.48% next-day decline followed by a 1.83% gain over the following five days. On October 30, 2025, actual EPS of $1.89 beat the $1.76 estimate by 7.4%, producing a 1.91% next-day gain but a 0.54% decline over the following five days.

Across the full eight-quarter sample, the average five-day post-earnings move is only 0.46%, classified as “flat.” The pattern is clear: AMETEK reliably tops estimates, but the market rarely reprices the stock aggressively after the print. The next scheduled release is October 29, 2026, before the market opens, with a consensus EPS estimate of $2.11.

For a deeper dive into how sell-side analysts and institutional investors currently view AMETEK—including consensus target ranges, rating revisions and forward estimates—review the full institutional verdict on the platform.